DK211489D0 - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK211489D0
DK211489D0 DK211489A DK211489A DK211489D0 DK 211489 D0 DK211489 D0 DK 211489D0 DK 211489 A DK211489 A DK 211489A DK 211489 A DK211489 A DK 211489A DK 211489 D0 DK211489 D0 DK 211489D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
idazoxan
carbidopa
alpha
mixture
Prior art date
Application number
DK211489A
Other languages
English (en)
Other versions
DK211489A (da
Inventor
Saad Al-Damluji
Original Assignee
Saad Al Damluji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saad Al Damluji filed Critical Saad Al Damluji
Publication of DK211489A publication Critical patent/DK211489A/da
Publication of DK211489D0 publication Critical patent/DK211489D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK211489A 1987-09-02 1989-05-01 Farmaceutisk praeparat DK211489D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878720600A GB8720600D0 (en) 1987-09-02 1987-09-02 Pharmaceutical compositions
PCT/GB1988/000717 WO1989001774A1 (en) 1987-09-02 1988-09-01 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK211489A DK211489A (da) 1989-05-01
DK211489D0 true DK211489D0 (da) 1989-05-01

Family

ID=10623138

Family Applications (1)

Application Number Title Priority Date Filing Date
DK211489A DK211489D0 (da) 1987-09-02 1989-05-01 Farmaceutisk praeparat

Country Status (8)

Country Link
US (1) US5015654A (da)
EP (1) EP0345304B1 (da)
JP (1) JPH02500596A (da)
AT (1) ATE81775T1 (da)
DE (1) DE3875611T2 (da)
DK (1) DK211489D0 (da)
GB (2) GB8720600D0 (da)
WO (1) WO1989001774A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109007A (en) * 1989-01-06 1992-04-28 The United States Of America As Represented By The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
US5663167A (en) * 1992-12-09 1997-09-02 The United States Of America As Represented By The Department Of Health And Human Services Antipsychotic composition and method of treatment
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
FR2759291A1 (fr) * 1997-02-13 1998-08-14 Pf Medicament Produit contenant de l'idazoxan et de la 1-dopa comme preparation pharmaceutique combinee utilise pour la maladie de parkinson
US20070010584A1 (en) * 2003-09-04 2007-01-11 Peroutka Stephen J Compositions and methods for orthostatic intolerance
PL1948155T3 (pl) * 2006-06-28 2012-10-31 Chelsea Therapeutics Inc Kompozycje farmaceutyczne zawierające droksidopę
BRPI0808647A2 (pt) * 2007-03-09 2014-08-12 Chelsea Therapeutics Inc Método para tratar a síndrome de sensibilidade central, método para reduzir, eliminar ou prevenir a dor associada à fibromialgia, kit útil para o tratamento de uma síndrome de sensibilidade central.
WO2008112773A2 (en) * 2007-03-12 2008-09-18 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
ES2431570T3 (es) * 2007-05-07 2013-11-27 Chelsea Therapeutics, Inc. Droxidopa y composición farmacéutica de la misma para el tratamiento de los trastornos por déficit de atención

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4673689A (en) * 1985-09-25 1987-06-16 Massachusetts Institute Of Technology Method and composition for enhancing the effect of indirect-acting sympathomimetic amines

Also Published As

Publication number Publication date
DK211489A (da) 1989-05-01
ATE81775T1 (de) 1992-11-15
DE3875611D1 (de) 1992-12-03
GB2209281A (en) 1989-05-10
JPH02500596A (ja) 1990-03-01
EP0345304A1 (en) 1989-12-13
WO1989001774A1 (en) 1989-03-09
GB2209281B (en) 1991-08-21
EP0345304B1 (en) 1992-10-28
US5015654A (en) 1991-05-14
GB8720600D0 (en) 1987-10-07
GB8820654D0 (en) 1988-10-05
DE3875611T2 (de) 1993-03-11

Similar Documents

Publication Publication Date Title
ITRM920155A1 (it) Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil1h-indol-5-metansolfonammide, relativo procedimento di preparazione e impiego della stessa nel trattamento di mammiferi
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
KR870005637A (ko) 약물 데포
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
NO865093D0 (no) Fremgangsmaate for fremstilling av n,n-dimetyl-1-(1-(4-klorfenyl)cyklobutyl)-3-metylbutylamin.
RU93004970A (ru) Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
DK261490D0 (da) New pharmaceutical compound
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
DK211489D0 (da) Farmaceutisk praeparat
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
SE8204288D0 (sv) Apap-anticidum-komposition
IE38655L (en) Pharmaceutical compositions
DE3872213D1 (de) 5-substituierte ornithin-derivate.
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES2032476T3 (es) Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina.
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
ATE74505T1 (de) Schmerzpraeparat.
KR900017599A (ko) 종양 치료용 약학 조성물
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
SE7806469L (sv) Antihypertensiva kompositioner
SE9000288D0 (sv) New use
IT8320325A0 (it) Composto ad attivita'analgesica, antipiretica, antiinfiammatoria e muscolorilassante, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment